{"name": "Tocagen",
 "permalink": "tocagen",
 "crunchbase_url": "http://www.crunchbase.com/company/tocagen",
 "homepage_url": "http://www.tocagen.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2007,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "858-412-8400",
 "description": "",
 "created_at": "Wed Mar 10 09:47:33 UTC 2010",
 "updated_at": "Wed Jun 12 11:59:30 UTC 2013",
 "overview": "\u003Cp\u003ETocagen Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of products for the treatment of cancer. It develops gene therapy products for treating a primary tumors and metastatic diseases. The company\u00e2\u20ac\u2122s products comprise Prodrug Activator product candidates for treating glioblastoma multiforme; and immunotherapeutic product candidates for treating metastatic malignant melanoma. Tocagen was founded in 2007 and is based in San Diego, California.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       58],
      "assets/images/resized/0007/9780/79780v1-max-150x150.jpg"],
     [[162,
       63],
      "assets/images/resized/0007/9780/79780v1-max-250x250.jpg"],
     [[162,
       63],
      "assets/images/resized/0007/9780/79780v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Chairman and CEO",
    "person":
     {"first_name": "Harry",
      "last_name": "E. Gruber",
      "permalink": "harry-e-gruber",
      "image": null}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "Thomas",
      "last_name": "E. Darcy",
      "permalink": "thomas-e-darcy",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$8.01M",
 "funding_rounds":
  [{"round_code": "d",
    "source_url": "http://www.fiercebiotech.com/also-noted/tocagen-raises-7-8m-ista-gets-pdufa-date/2010-03-09?utm_medium=rss\u0026utm_source=rss",
    "source_description": "Tocagen raises $7.8M; ISTA gets PDUFA date",
    "raised_amount": 7800000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 3,
    "funded_day": 9,
    "investments":
     []},
   {"round_code": "partial",
    "source_url": "http://www.sec.gov/Archives/edgar/data/1419041/000141904113000001/xslFormDX01/primary_doc.xml",
    "source_description": "SEC",
    "raised_amount": 210000.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 6,
    "funded_day": 10,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "3030 Bunker Hill Street",
    "address2": "Suite 230",
    "zip_code": "92109",
    "city": "San Diego",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        100],
       "assets/images/resized/0007/9823/79823v2-max-150x150.png"],
      [[250,
        168],
       "assets/images/resized/0007/9823/79823v2-max-250x250.png"],
      [[450,
        302],
       "assets/images/resized/0007/9823/79823v2-max-450x450.png"]],
    "attribution": null}],
 "external_links":
  []}